WORLD-TECHNOLOGY-GAMES
25.7.2024 15:01:31 CEST | Business Wire | Press release
The World Technology Games (WTG), a groundbreaking global competition in innovation, technology and science, announced its inaugural event for Q3 2026. The annual, five-day event will include Competitions, a Festival and a Leadership Summit. The Games will celebrate and elevate advancements across Life, Earth, Data and Industrial Sciences, through unifying themes like sustainability and AI.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725287146/en/
World Technology Games CEO Alexander Brown and Gabriela Ramos, Assistant Director-General for the Social and Human Sciences of UNESCO, at The UNESCO “Change the Game” Ministerial Sport Conference in Paris on July 23, 2024. (Photo: Business Wire)
“We built the World Technology Games to inspire people around the world to create technological solutions for today’s most formidable challenges,” said Alexander Brown, CEO of the World Technology Games. “Our first-of-its-kind international event will convene brilliant minds from diverse backgrounds to compete, collaborate, and catalyze change at global scale.”
The World Technology Games were showcased by Mr. Brown at the UNESCO “Change the Game” Global Sport Conference as France hosts the 2024 Olympic Games. The WTG underscored its commitment to support key UN Sustainable Development Goals and to UNESCO’s vision of building multilateral collaboration on education, science, culture, communication and information.
The WTG will honor the ambition, competitive spirit and ingenuity that drive today’s greatest technological contributions. An international cohort of scientists, engineers and innovators will unite for two categories of cutting-edge competitions that aim to entertain and empower people through technology, passion and purpose. “Spotlights” are organized in partnership with established leagues, including support from the Indy Autonomous Challenge and the Global Esports Federation. Unique to the Games, “Originals” are characterized by scientific rigor, real-world application and technological acumen, including culinary creativity, sustainable fashion design, robotics and more.
Through the live event and digital content, the WTG targets a global audience of more than 1.6 billion people who consider technology an essential component of their daily lives. With a focus on engaging Gen T – the nearly 700 million individuals globally who are poised to shape the future of technology – the Games will be amplified by a multi-channel approach distributed across social, digital, podcasts, streaming platforms and linear broadcast.
The WTG is led by Alexander Brown. Mr. Brown has a proven track record of building and growing businesses at a global scale including serving as Managing Director of ESPN Asia and ESPN Star Sports, as well as leadership positions with the NBA, Univision and One World Sports. Brown also served as President & CEO of CNBC Asia. Chairman of the Board, Paul J. Foster is CEO & Member of the Board for the Global Esports Federation and focuses on integrating innovative technology with social impact. He brings more than 20 years of experience in the Olympic Movement, an extensive tenure at the International Olympic Committee and global strategic consulting. The WTG is championed by an International Advisory Council of multidisciplinary experts from more than 20 countries who have spearheaded the growth of global companies and organizations across science, technology, diplomacy, entertainment, and finance.
The Games will also feature an immersive festival and thought leadership summit. The World Technology Festival will celebrate the intersection of technology, art and culture through exhibitions, product showcases and workshops. The World Technology Summit will convene industry experts with keynote speeches, debates and expert panels to explore future trends and the transformative potential of technology.
The inaugural host city selection has begun, with cities worldwide encouraged to submit expressions of interest through September 2024. For more information on the World Technology Games please visit: https://worldtechnology.games/.
About the World Technology Games:
The World Technology Games (WTG) is a global, first-of-its-kind competition celebrating human ingenuity in Life, Earth, Data and Industrial sciences. Set to debut in 2026, the annual five-day event will convene scientists, engineers and innovators from around the world for a series of cutting-edge competitions, a festival and a leadership summit that address humanity’s greatest challenges through technology, passion and purpose. Led by an accomplished leadership team of global multidisciplinary experts, the WTG will empower and entertain a worldwide audience by honoring the unheralded, yet brilliant minds behind today’s greatest advancements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725287146/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom